Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 9.17x is 45% below its estimated 2-year average of 16.79x, near the low end of its estimated 2-year range (5.10x–42.09x).
As of 2026-10-06T16:34:09.337Z. 48.34% below its estimated 12-month average of 17.75x.
Calculation as of: 2026-10-06T16:34:09.337Z.
Quote observation: 2026-10-06T16:30:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 09a0ab09da9db255713b3d52bc1d4f6ff3c974c87d2899d50b33d975ee1631b8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
9.17x
EV/SALES RATIO AVG TTM
17.75x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-48.34%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 481 covered companies
CURRENT VS SECTOR MEDIAN
+118.33%
vs the sector median at left
Prelude Therapeutics Incorporated
Market Cap
$214.35M
EV/Sales Ratio
9.17x
TTM Avg
17.75x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$214.39M
EV/Sales Ratio
1.16x
TTM Avg
2.73x
3Y Avg
3.49x
5Y Avg
2.89x
Market Cap
$218.36M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$218.09M
EV/Sales Ratio
6742.14x
TTM Avg
8843.11x
3Y Avg
4911.03x
5Y Avg
2972.75x
Market Cap
$208.90M
EV/Sales Ratio
84.73x
TTM Avg
65.28x
3Y Avg
31.25x
5Y Avg
19.18x
Market Cap
$221.27M
EV/Sales Ratio
N/A
TTM Avg
0.28x
3Y Avg
11342.46x
5Y Avg
7406.39x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prelude Therapeutics Incorporated (PRLD) | $214.35M | 9.17x | 17.75x | N/A | N/A |
| Niagen Bioscience Inc (NAGE)vs › | $214.39M | 1.16x | 2.73x | 3.49x | 2.89x |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $218.36M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $211.80M | 2.76x | 9.07x | 6.60x | 11.04x |
| Alector, Inc. (ALEC)vs › | $217.34M | 13.72x | 7.34x | 5.26x | 6.10x |
| Lyell Immunopharma, Inc. (LYEL)vs › | $218.09M | 6742.14x | 8843.11x | 4911.03x | 2972.75x |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $208.90M | 84.73x | 65.28x | 31.25x | 19.18x |
| Sionna Therapeutics, Inc. (SION)vs › | $209.27M | N/A | N/A | N/A | N/A |
| Keros Therapeutics, Inc. (KROS)vs › | $221.27M | N/A | 0.28x | 11342.46x | 7406.39x |
| Pro-Dex, Inc. (PDEX)vs › | $206.63M | 2.79x | 2.41x | 2.22x | 2.09x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 16.15x |
| 2026-10-02 | 15.72x |
| 2026-10-01 | 16.24x |
| 2026-09-30 | 16.77x |
| 2026-09-29 | 16.99x |
| 2026-09-28 | 16.77x |
| 2026-09-25 | 16.64x |
| 2026-09-24 | 17.12x |
| 2026-09-23 | 18.52x |
| 2026-09-22 | 20.89x |
| 2026-09-21 | 20.23x |
| 2026-09-18 | 20.98x |
| 2026-09-17 | 19.66x |
| 2026-09-16 | 19.23x |
| 2026-09-15 | 19.45x |
| 2026-09-14 | 19.75x |
| 2026-09-11 | 19.75x |
| 2026-09-10 | 20.10x |
| 2026-09-09 | 21.95x |
| 2026-09-08 | 22.87x |
| 2026-09-04 | 23.57x |
| 2026-09-03 | 22.65x |
| 2026-09-02 | 23.44x |
| 2026-09-01 | 23.70x |
| 2026-08-31 | 24.18x |
| 2026-08-28 | 23.61x |
| 2026-08-27 | 27.43x |
| 2026-08-26 | 28.40x |
| 2026-08-25 | 28.53x |
| 2026-08-24 | 28.00x |
| 2026-08-21 | 28.70x |
| 2026-08-20 | 28.13x |
| 2026-08-19 | 24.97x |
| 2026-08-18 | 24.84x |
| 2026-08-17 | 24.32x |
| 2026-08-14 | 23.96x |
| 2026-08-13 | 23.13x |
| 2026-08-12 | 24.75x |
| 2026-08-11 | 26.02x |
| 2026-08-10 | 23.60x |
| 2026-08-07 | 23.94x |
| 2026-08-06 | 22.86x |
| 2026-08-05 | 22.17x |
| 2026-08-04 | 22.07x |
| 2026-08-03 | 21.43x |
| 2026-07-31 | 22.46x |
| 2026-07-30 | 24.68x |
| 2026-07-29 | 23.00x |
| 2026-07-28 | 22.66x |
| 2026-07-27 | 18.96x |
| 2026-07-24 | 18.66x |
| 2026-07-23 | 19.15x |
| 2026-07-22 | 19.15x |
| 2026-07-21 | 19.70x |
| 2026-07-20 | 19.80x |
| 2026-07-17 | 20.49x |
| 2026-07-16 | 20.39x |
| 2026-07-15 | 21.77x |
| 2026-07-14 | 21.43x |
| 2026-07-13 | 21.67x |
| 2026-07-10 | 23.50x |
| 2026-07-09 | 23.99x |
| 2026-07-08 | 25.03x |
| 2026-07-07 | 24.29x |
| 2026-07-06 | 24.39x |
| 2026-07-02 | 23.99x |
| 2026-07-01 | 23.99x |
| 2026-06-30 | 26.06x |
| 2026-06-29 | 24.09x |
| 2026-06-26 | 21.38x |
| 2026-06-25 | 19.99x |
| 2026-06-24 | 20.83x |
| 2026-06-23 | 21.38x |
| 2026-06-22 | 21.08x |
| 2026-06-18 | 21.08x |
| 2026-06-17 | 21.23x |
| 2026-06-16 | 20.49x |
| 2026-06-15 | 21.77x |
| 2026-06-12 | 21.92x |
| 2026-06-11 | 20.04x |
| 2026-06-10 | 19.25x |
| 2026-06-09 | 19.20x |
| 2026-06-08 | 18.71x |
| 2026-06-05 | 18.56x |
| 2026-06-04 | 19.90x |
| 2026-06-03 | 17.82x |
| 2026-06-02 | 17.03x |
| 2026-06-01 | 18.61x |
| 2026-05-29 | 19.11x |
| 2026-05-28 | 19.15x |
| 2026-05-27 | 20.29x |
| 2026-05-26 | 19.94x |
| 2026-05-22 | 20.83x |
| 2026-05-21 | 21.13x |
| 2026-05-20 | 21.97x |
| 2026-05-19 | 20.83x |
| 2026-05-18 | 21.18x |
| 2026-05-15 | 21.87x |
| 2026-05-14 | 21.82x |
| 2026-05-13 | 22.76x |
| 2026-05-12 | 22.62x |
| 2026-05-11 | 23.45x |
| 2026-05-08 | 23.76x |
| 2026-05-07 | 25.27x |
| 2026-05-06 | 23.66x |
| 2026-05-05 | 22.78x |
| 2026-05-04 | 23.14x |
| 2026-05-01 | 22.93x |
| 2026-04-30 | 25.68x |
| 2026-04-29 | 20.70x |
| 2026-04-28 | 21.33x |
| 2026-04-27 | 22.00x |
| 2026-04-24 | 22.93x |
| 2026-04-23 | 21.38x |
| 2026-04-22 | 20.91x |
| 2026-04-21 | 22.52x |
| 2026-04-20 | 21.95x |
| 2026-04-17 | 21.59x |
| 2026-04-16 | 21.53x |
| 2026-04-15 | 27.19x |
| 2026-04-14 | 21.38x |
| 2026-04-13 | 21.22x |
| 2026-04-10 | 19.72x |
| 2026-04-09 | 21.38x |
| 2026-04-08 | 20.44x |
| 2026-04-07 | 21.38x |
| 2026-04-06 | 17.64x |
| 2026-04-02 | 16.50x |
| 2026-04-01 | 16.45x |
| 2026-03-31 | 16.30x |
| 2026-03-30 | 14.48x |
| 2026-03-27 | 14.38x |
| 2026-03-26 | 15.36x |
| 2026-03-25 | 15.47x |
| 2026-03-24 | 14.74x |
| 2026-03-23 | 14.95x |
| 2026-03-20 | 14.07x |
| 2026-03-19 | 15.10x |
| 2026-03-18 | 14.74x |
| 2026-03-17 | 16.35x |
| 2026-03-16 | 15.98x |
| 2026-03-13 | 15.67x |
| 2026-03-12 | 16.04x |
| 2026-03-11 | 18.32x |
| 2026-03-10 | 23.28x |
| 2026-03-09 | 19.58x |
| 2026-03-06 | 20.59x |
| 2026-03-05 | 19.80x |
| 2026-03-04 | 17.55x |
| 2026-03-03 | 16.24x |
| 2026-03-02 | 16.82x |
| 2026-02-27 | 17.19x |
| 2026-02-26 | 17.98x |
| 2026-02-25 | 21.03x |
| 2026-02-24 | 17.91x |
| 2026-02-23 | 17.26x |
| 2026-02-20 | 17.33x |
| 2026-02-19 | 13.63x |
| 2026-02-18 | 12.76x |
| 2026-02-17 | 12.47x |
| 2026-02-13 | 13.34x |
| 2026-02-12 | 13.42x |
| 2026-02-11 | 12.33x |
| 2026-02-10 | 12.40x |
| 2026-02-09 | 12.76x |
| 2026-02-06 | 12.91x |
| 2026-02-05 | 11.82x |
| 2026-02-04 | 13.85x |
| 2026-02-03 | 13.78x |
| 2026-02-02 | 11.89x |
| 2026-01-30 | 10.59x |
| 2026-01-29 | 10.95x |
| 2026-01-28 | 11.46x |
| 2026-01-27 | 12.55x |
| 2026-01-26 | 11.89x |
| 2026-01-23 | 11.82x |
| 2026-01-22 | 13.20x |
| 2026-01-21 | 10.37x |
| 2026-01-20 | 10.51x |
| 2026-01-16 | 10.30x |
| 2026-01-15 | 12.76x |
| 2026-01-14 | 13.56x |
| 2026-01-13 | 13.42x |
| 2026-01-12 | 13.13x |
| 2026-01-09 | 16.24x |
| 2026-01-08 | 17.19x |
| 2026-01-07 | 17.69x |
| 2026-01-06 | 15.74x |
| 2026-01-05 | 14.87x |
| 2026-01-02 | 16.97x |
| 2025-12-31 | 18.20x |
| 2025-12-30 | 17.77x |
| 2025-12-29 | 18.49x |
| 2025-12-26 | 14.94x |
| 2025-12-24 | 13.34x |
| 2025-12-23 | 13.05x |
| 2025-12-22 | 13.56x |
| 2025-12-19 | 12.69x |
| 2025-12-18 | 11.09x |
| 2025-12-17 | 11.31x |
| 2025-12-16 | 11.60x |
| 2025-12-15 | 11.24x |
| 2025-12-12 | 9.57x |
| 2025-12-11 | 8.99x |
| 2025-12-10 | 9.14x |
| 2025-12-09 | 9.50x |
| 2025-12-08 | 7.76x |
| 2025-12-05 | 7.76x |
| 2025-12-04 | 8.34x |
| 2025-12-03 | 7.18x |
| 2025-12-02 | 6.96x |
| 2025-12-01 | 8.41x |
| 2025-11-28 | 9.35x |
| 2025-11-26 | 9.28x |
| 2025-11-25 | 8.70x |
| 2025-11-24 | 7.32x |
| 2025-11-21 | 9.28x |
| 2025-11-20 | 8.77x |
| 2025-11-19 | 9.28x |
| 2025-11-18 | 9.35x |
| 2025-11-17 | 9.14x |
| 2025-11-14 | 8.19x |
| 2025-11-13 | 8.12x |
| 2025-11-12 | 14.84x |
| 2025-11-11 | 13.54x |
| 2025-11-10 | 12.56x |
| 2025-11-07 | 11.80x |
| 2025-11-06 | 13.54x |
| 2025-11-05 | 13.97x |
| 2025-11-04 | 17.99x |
| 2025-11-03 | 42.09x |
| 2025-10-31 | 16.14x |
| 2025-10-30 | 15.93x |
| 2025-10-29 | 16.03x |
| 2025-10-28 | 15.60x |
| 2025-10-27 | 17.44x |
| 2025-10-24 | 16.47x |
| 2025-10-23 | 15.17x |
| 2025-10-22 | 16.03x |
| 2025-10-21 | 16.69x |
| 2025-10-20 | 12.89x |
| 2025-10-17 | 11.80x |
| 2025-10-16 | 13.10x |
| 2025-10-15 | 13.65x |
| 2025-10-14 | 12.99x |
| 2025-10-13 | 12.45x |
| 2025-10-10 | 12.56x |
| 2025-10-09 | 14.08x |
| 2025-10-08 | 14.30x |
| 2025-10-07 | 14.51x |
| 2025-10-06 | 14.73x |
| 2025-10-03 | 14.84x |
| 2025-10-02 | 14.51x |
| 2025-10-01 | 15.27x |
| 2025-09-30 | 14.51x |
| 2025-09-29 | 13.75x |
| 2025-09-26 | 15.17x |
| 2025-09-25 | 12.13x |
| 2025-09-24 | 11.58x |
| 2025-09-23 | 10.06x |
Showing the most recent 260 of 477 data points. The chart above shows the full history.
